Why Your Joint Supplements Aren't Working After Long COVID — and What to Do Differently
If you've been experiencing persistent joint pain after COVID-19, you've likely already tried the obvious things. Anti-inflammatories. Rest. Glucosamine supplements. Physio.
And if you're still searching for answers, you're not alone — and you're probably not doing anything wrong.
The issue may not be what you're taking. It may be whether it's actually getting there.
The absorption problem with oral glucosamine
When you swallow a glucosamine supplement, up to 95% of the active ingredient is lost through digestion and liver metabolism before it reaches the joint. This is not a minor caveat — it's a fundamental limitation that researchers and healthcare professionals have raised repeatedly. Even at the standard recommended dose of 1,500mg daily, studies have found that oral glucosamine barely reaches the therapeutic concentration needed in joint tissue.
For someone whose body has been through a systemic inflammatory event like COVID-19 — where immune function, gut health, and tissue integrity have all been affected — that absorption gap is wider still.
This is why many people with Long COVID joint pain continue supplementing diligently and still feel little improvement. The mechanism of delivery is working against them.
Why Long COVID joint pain is different
Research suggests that persistent joint pain after COVID-19 is largely inflammatory in nature. The joint may not be structurally damaged the way an injury would cause, but the tissue environment surrounding it is disrupted — immune dysregulation and accelerated local tissue stress appear to be contributing factors.
What the joint needs isn't necessarily more systemic input through a digestive system already under strain. It needs targeted support that can reach the tissue directly.
A different delivery
URAH MD (Micellar Delivered) glucosamine is applied directly to the skin. Independent research published in BMC Research Notes (vol. 9, article 254, 2016) found that URAH's micellar transdermal delivery achieves up to 10 times more absorption than oral glucosamine pills — bypassing the digestive process entirely.
No GI side effects. No additional burden on a system already working to recover. Support delivered where the disruption is occurring.
URAH has been in the market since 2001, continuously refined. It was voluntarily submitted for clinical study. It is recommended by healthcare professionals and stocked in hospitals and clinics. More than a million units have been sold. Over 80% of customers return.
If you've been trying to address Long COVID joint pain from the inside out — it may be time to try the other direction.
*Peer-reviewed studies available at umicellar.com. Verified customer reviews at umicellar.com. No GI side effects.*
